New search | Conferencedetail
Print view
 
 

2nd Gene Therapy for Ophthalmic Disorders

Evvnt Promotion / evvnt
-
21.09.2021 - 23.09.2021  Online
Time: 8:00 am - 5:00 pm
 
Conference themes
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.

Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Scientific Society
Hanson Wade
Notes
Brochure: https://go.evvnt.com/780504-0?pid=4832

Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
 

Enquiries and Registration:

https://go.evvnt.com/780504-1?pid=4832
Ms. Ellie Saunders
 
Categories
General Medicine
Languages
English
Congress fees
USD 1599.00 - USD 3296.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Alumni Club Medizinische Universität WienHilfswerk AustriaCenter of ExcellenceAMREF - African Medical and Research FoundationAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Health Forum GasteinÄrztekammer für Wien